Schering-Plough Business Segments — Salaries and benefits remained flat by 0.0% to $2.94M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 63.3%, from $1.80M to $2.94M. This is a positive signal — lower values indicate better performance for this metric.
An increase typically reflects headcount growth or higher compensation to attract specialized talent, while a decrease may indicate cost-cutting or reduced operational scale.
Represents the total compensation costs, including wages, bonuses, and benefits, for personnel directly associated with...
Standard across biopharma companies as 'Selling, General, and Administrative' or 'Research and Development' personnel costs.
sgp_segment_reporting_segment_salaries_and_benefits| FY'24 | FY'25 | |
|---|---|---|
| Value | $7.20M | $11.76M |
| YoY Change | — | +63.3% |